Effect of mean platelet volume on postintervention coronary blood flow in patients with chronic stable angina pectoris

Journal of Invasive Cardiology

Volumn 20, Issue 3, 2008, Pages 120-124

  Duygu, Hamza ^a   Turkoglu, Cuneyt ^a   Kirilmaz, Bahadir ^a   Turk, Ugur ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Coronary flow; Platelet function; Stable coronary artery disease

Indexed keywords

ADULT; ARTICLE; BLOOD CLOT LYSIS; BLOOD SAMPLING; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; DISEASE MARKER; EARLY DIAGNOSIS; FEMALE; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; LABORATORY TEST; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PROSPECTIVE STUDY; STABLE ANGINA PECTORIS; THROMBOCYTE VOLUME; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; BLOOD PLATELETS; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY VESSELS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENT ADMISSION; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 40449105713     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Van der Loo B, Martin JF. A role for changes in platelet production in the cause of acute coronary syndromes. Arterioscler Thromb Vasc Biol 1999;19:672-679.
2. Pizzulli L, Yang A, Martin JF, Luderitz B. Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur Heart J 1998;19:80-84.
3. Martin JF, Trowbridge EA, Salmon G, Plumb J. The biological significance of platelet volume: Its relationship to bleeding time, thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 1983;32:443-460.
4. Thaulow E, Erikssen J, Sandvik L, et al. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 1991;84:613-617.
5. Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: A quantitative method of assessing coronary artery flow. Circulation 1996;93:879-888.
6. The TIMI Study Group. Thrombolysis in myocardial infarction (TIMI) trial. N Engl J Med 1985;312:932-936.
7. Martin JF, Shaw T, Heggie J, Penington DG. Measurement of the density of human platelets and its relationship to volume. Br J Haematol 1983;54:337-352.
8. Thompson CB, Eaton KA, Princiotta SM, et al. Size dependent platelet subpopulation relationships of platelet volume to ultrastructure, enzymatic activity and function. Br J Haematol 1982;50:509-519.
9. Thompson CB, Jakubowski JA, Quinn PG, et al. Platelet size as a determinant of platelet function. J Lab Clin Med 1983;101:205-213.
10. Giles H, Smith RE, Martin JF. Platelet glycoprotein IIb-IIIa and size are increased in acute myocardial infarction. Eur J Clin Invest 1994;24:69-72.
11. Haver VM, Gear AR. Functional fractionation of platelets. J Lab Clin Med 1981;97:187-204.
12. Schultheiss HP, Tschoepe D, Esser J, et al. Large platelets continue to circulate in an activated state after myocardial infarction. Eur J Clin Invest 1994;24:243-247.
13. O'Malley T, Langhorne P, Elton RA, Stewart C. Platelet size in stroke patients. Stroke 1995;26:995-999.
14. Rao AK, Goldberg RE, Walsh PN. Platelet coagulant activities in diabetes mellitus. Evidence for relationship between platelet coagulant hyperactivity and platelet volume. J Lab Clin Med 1984;103:82-92.
15. Martin JF, Bath PM, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991;338:1409-1411.
16. Yilmaz MB, Cihan G, Guray Y, et al. Role of mean platelet volume in triaging acute coronary syndromes. J Thromb Thrombolysis August 20, 2007 [Epub ahead of print].
17. Piana RN, Paik GY, Moscucci M, et al. Incidence and treatment of "no-reflow" after percutaneous transluminal coronary intervention. Circulation 1994;89:2514-2518.
18. Abbo KM, Dooris M, Glazier S. Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol 1995;75:778-782.
19. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 2002;105:656-662.
20. Morishima I, Sone T, Okumura K, et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 2000;36:1202-1209.
21. Reffelmann T, Kloner RA. The no-reflow phenomenon: Basic science and clinical correlates. Heart 2002;87:162-168.
22. Topol EJ, Yadav JS. Recognition of the importance of embolitization in atherosclerosis vascular disease. Circulation 2002;101:570-580.
23. Arteaga C, Revel D, Zhao S, et al. Myocardial "low reflow" assessed by Dy-DTPA-BMA-enhanced first-pass MR imaging in a dog model. J Magn Reson Imaging 1999;9:679-684.
24. Kloner RA, Ganote CE, Jennings RB, Reimer KA. Demonstration of the "no-reflow" phenomenon in the dog heart after temporary ischemia. Recent Adv Stud Cardiac Struct Metab 1975;10:463-474.
25. Kloner RA, Rude RE, Carlson N, et al. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: Which comes first? Circulation 1980;62:945-952.
26. Michaels AD, Gibson CM, Barron HV. Microvascular dysfunction in acute myocardial infarction: Focus on the roles of platelet and inflammatory mediators in the noreflow phenomenon. Am J Cardiol 2000;85:50b-60b.
27. Simes RJ, Topol EJ, Holmes DR Jr, et al. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. Circulation 1995;91:1923-1928.
28. DeRouen TA, Murray JA, Owen W. Variability in the analysis of coronary arteriograms. Circulation 1977;55:324-328.
29. Gibson CM, Goel M, Cohen DJ, et al. Six-month angiographic and clinical follow-up of patients prospectively randomized to receive either tirofiban or placebo during angioplasty in the RESTORE trial: Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis. J Am Coll Cardiol 1998;32:28-34.
30. Kern MJ, Moore JA, Aguerre FV, et al. Determination of angiographic (TIMI grade) blood flow by intracoronary Doppler flow velocity during acute myocardial infarction. Circulation 1996;94:1545-1552.
31. Manginas A, Gatzov P, Chasikidis C, et al. Estimation of coronary flow reserve using the thrombolysis in myocardial infarction (TIMI) frame count method. Am J Cardiol 1999;83:1562-1565.
32. Faile BA, Guzzo JA, Tate DA, et al. Effect of sex, hemodynamics, body size, and other clinical variables on the corrected thrombolysis in myocardial infarction frame count used as an assessment of coronary blood flow. Am Heart J 2000;140:308-314.
33. Gibson CM, Murphy SA, Rizzo MJ, et al. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Circulation 1999;99:1945-1950.
34. Tsiara S, Elisaf M, Jagroop IA, Mikhailidis DP. Platelets as predictors of vascular risk: Is there a practical index of platelet activity? Clin Appl Thromb Hemost 2003;9:177-190.
35. Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996;7:157-161.
36. Endler G, Klimesch A, Sunder-Plassmann H, et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2002;117:399-404.